ShockWave Medical (SWAV)
(Real Time Quote from BATS)
$330.10 USD
+0.59 (0.18%)
Updated Apr 30, 2024 10:34 AM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
SWAV 330.10 +0.59(0.18%)
Will SWAV be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SWAV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SWAV
Should Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) Be on Your Investing Radar?
Why the Market Dipped But Shockwave Medical (SWAV) Gained Today
SWAV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Invesco S&P MidCap 400 GARP ETF (GRPM) a Strong ETF Right Now?
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
Other News for SWAV
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
Artisan Mid Cap Fund Q1 2024 Commentary
Artisan Global Discovery Fund Q1 2024 Commentary
Baron Health Care Fund Q1 2024 Shareholder Letter
Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.